ARS-Patent writes about new domestic regulations intended to fight evergreening of pharmaceutical patents May 14, 2019 Anna Pustogvar, patent expert at ARS-Patent, and Kirill Osipov, the Head of Legal Department of ARS-Patent, have been published in spring Newsletters of the AIPLA Chemical Practice Committee. They write about new domestic regulations intended to prevent evergreening of pharmaceutical patents. Read the publication here (the PDF version is provided by AIPLA Chemical Practice Committee) Make an enquiry
MEET WITH US ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read moreARS-Patent at AIPPI World Congress 2025 in Yokohama2025-08-18The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...Read moreSee all Events
ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read more
ARS-Patent at AIPPI World Congress 2025 in Yokohama2025-08-18The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...Read more
